Laven Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.00 M
as on 11-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 11-12-2024
- Revenue 2.24%
(FY 2020)
- Profit 17.89%
(FY 2020)
- Ebitda 171.23%
(FY 2020)
- Net Worth 13.96%
(FY 2020)
- Total Assets -5.17%
(FY 2020)
About Laven Pharma India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 M.
Kishan Tadiparthi and Harakishore Tadiparthy serve as directors at the Company.
- CIN/LLPIN
U24231TN2005PTC055230
- Company No.
055230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Laven Pharma India Private Limited offer?
Laven Pharma India Private Limited offers a wide range of products and services, including Pharma Franchise, Pharmaceutical Distributors, Diabetic Medicines, Vitamins, Minerals & Antioxidants.
Who are the key members and board of directors at Laven Pharma India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishan Tadiparthi  | Director | 27-Jan-2005 | Current |
| Harakishore Tadiparthy | Whole-Time Director | 27-Jan-2005 | Current |
Financial Performance of Laven Pharma India.
Laven Pharma India Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.24% increase. The company also saw a substantial improvement in profitability, with a 17.89% increase in profit. The company's net worth Soared by an impressive increase of 13.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laven Pharma India?
In 2019, Laven Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karur Vysya Bank Limited Creation Date: 07 Feb 2012 | ₹2.00 M | Open |
How Many Employees Work at Laven Pharma India?
Unlock and access historical data on people associated with Laven Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laven Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laven Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
